Why did Louvre Museum close after jewelry heist?
How is AI spending impacting US GDP growth?
What caused broad layoffs at Broadcom post-VMware deal?
Why is gold surging amid economic uncertainty?
How could US-China chipmaker dispute affect auto industry?
What’s behind Tesla stock underperforming recently?
How are AI startups attracting talent with housing perks?
Tvardi Therapeutics' Lung Disease Candidate Fails To Show Any Clinical Benefit, Stock Sinks
benzinga.com/news/health-care/25/10/48184263/tvardi-therapeutics-lung-disease-candidate-fails-to-show-any-clinical-benefit-stock-sinks
Tvardi Therapeutics Inc. (NASDAQ:TVRD) stock is falling on Monday with a session volume of 5.56 million versus the average volume of 42.08 thousand, as per data from Benzinga Pro.
Tvardi Therapeutics provided an update on preliminary data from the Phase 2 REVERT trial of TTI-101 alone or…
This story appeared on benzinga.com, 2025-10-13 18:23:45.